Trial
NCT01195779
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Influenza
Intervention
GSK Bio's influenza vaccine GSK2584786A, different formulations
Why stopped
The study was terminated for logistic reasons not related to safety or efficacy of the vaccine.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-30